# Heineken warns UK pubs: Weight-loss drugs could hit beer sales

> Heineken urges UK pubs to adapt as weight-loss drugs reduce beer sales.
- Title: Heineken warns UK pubs: Weight-loss drugs could hit beer sales
- Summary: Heineken urges UK pubs to adapt as weight-loss drugs reduce beer sales. Heineken warns UK pubs that GLP-1 weight-loss drugs could cut beer sales by 7% as…
- Keywords: heineken, glp-1, beer sales, uk pubs, weight-loss drugs, ozempic, wegovy, novonordisk, jpmorgan, circana, news, india
- Source: mint — https://livemint.com/companies/news/heineken-warns-uk-pubs-weight-loss-drugs-could-hit-beer-sales-11792745387965.html
- Published: 2026-10-23T08:59:09+00:00
- Read time: 1 min
- Topics: heineken, glp-1, beer sales, uk pubs, weight-loss drugs, ozempic, wegovy, novonordisk, jpmorgan, circana, news, india
## Heineken warns UK pubs
Heineken urges British pubs to adapt to weight-loss drugs or risk losing customers and revenue.

> Heineken Warns Pubs to Adapt as Weight-Loss Drugs Curb Drinking
## GLP-1 use surges
JPMorgan research shows 10 million US users took weight-loss drugs like Ozempic and Wegovy last year.
## GLP-1 impacts drinking
GLP-1 users reduced alcohol spending by 7% monthly compared to non-users after two years on the drugs.
## Heineken's advice
Heineken advises pubs to promote half-pints, low-alcohol drinks, and pair with small plates to retain customers.
## Beer sales in UK
Beer sales in UK pubs generated £14 billion annually with less than £300 million from low-alcohol beers.
## GLP-1 users cut drinking
Ten of 11 GLP-1 users surveyed said they reduced drinking significantly due to discomfort or loss of desire.
## Heineken's stance
Heineken says GLP-1 users are shifting to smaller serves and premium products but beer sales may decline.
## Key takeaway

Heineken warns UK pubs that GLP-1 weight-loss drugs could cut beer sales by 7% as users opt for smaller drinks.